Deutsche Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Deutsche Bank’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-600	Closed	-$1K	–	5898
2013 Q3	$1K	Buy	+600	New	+$11.6K	﹤0.01%	5478

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Deutsche Bank's ARIA Position: Q1 2017 in Review

Deutsche Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,225,891 shares — an estimated $15.2M sold.

Deutsche Bank first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $33.2M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Deutsche Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Deutsche Bank sold 1,225,891 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $15.2M.
Deutsche Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Deutsche Bank's Ariad Pharmaceuticals Inc position peaked at $33.2M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Deutsche Bank's 13F filing for Q1 2017, filed 15 May 2017.